Tactile Systems Technology Past Earnings Performance
Past criteria checks 2/6
Tactile Systems Technology has been growing earnings at an average annual rate of 23.4%, while the Medical Equipment industry saw earnings growing at 12% annually. Revenues have been growing at an average rate of 10.5% per year. Tactile Systems Technology's return on equity is 7.4%, and it has net margins of 5.4%.
Key information
23.4%
Earnings growth rate
19.0%
EPS growth rate
| Medical Equipment Industry Growth | 8.9% |
| Revenue growth rate | 10.5% |
| Return on equity | 7.4% |
| Net Margin | 5.4% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Tactile Systems Technology, Inc. Just Recorded A 18% EPS Beat: Here's What Analysts Are Forecasting Next
Nov 07
Investors Holding Back On Tactile Systems Technology, Inc. (NASDAQ:TCMD)
Jul 17US$20.67: That's What Analysts Think Tactile Systems Technology, Inc. (NASDAQ:TCMD) Is Worth After Its Latest Results
May 09Tactile Systems Technology, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next
Feb 23Does Tactile Systems Technology (NASDAQ:TCMD) Have A Healthy Balance Sheet?
Oct 10Capital Allocation Trends At Tactile Systems Technology (NASDAQ:TCMD) Aren't Ideal
Sep 16Is It Time To Consider Buying Tactile Systems Technology, Inc. (NASDAQ:TCMD)?
Jul 13Are Investors Undervaluing Tactile Systems Technology, Inc. (NASDAQ:TCMD) By 26%?
May 10Is Tactile Systems Technology (NASDAQ:TCMD) Using Too Much Debt?
Feb 16Is Tactile Systems Technology (NASDAQ:TCMD) A Risky Investment?
Oct 12Tactile Systems Technology GAAP EPS of -$0.23 misses by $0.09, revenue of $59.6M beats by $2.72M
Aug 01Is Tactile Systems Technology (NASDAQ:TCMD) A Risky Investment?
Jun 14Investors Could Be Concerned With Tactile Systems Technology's (NASDAQ:TCMD) Returns On Capital
Jan 20Some Investors May Be Worried About Tactile Systems Technology's (NASDAQ:TCMD) Returns On Capital
May 20Revenue & Expenses Breakdown
How Tactile Systems Technology makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 285 | 15 | 176 | 9 |
| 30 Jun 24 | 282 | 33 | 173 | 8 |
| 31 Mar 24 | 277 | 28 | 171 | 8 |
| 31 Dec 23 | 274 | 29 | 169 | 8 |
| 30 Sep 23 | 271 | 25 | 168 | 8 |
| 30 Jun 23 | 266 | 0 | 168 | 8 |
| 31 Mar 23 | 258 | -4 | 169 | 8 |
| 31 Dec 22 | 247 | -18 | 167 | 7 |
| 30 Sep 22 | 235 | -30 | 165 | 7 |
| 30 Jun 22 | 222 | -31 | 159 | 7 |
| 31 Mar 22 | 213 | -25 | 150 | 6 |
| 31 Dec 21 | 208 | -12 | 143 | 6 |
| 30 Sep 21 | 206 | 8 | 138 | 5 |
| 30 Jun 21 | 202 | 14 | 133 | 5 |
| 31 Mar 21 | 186 | -2 | 127 | 5 |
| 31 Dec 20 | 187 | -1 | 131 | 5 |
| 30 Sep 20 | 185 | -8 | 127 | 5 |
| 30 Jun 20 | 185 | -8 | 125 | 5 |
| 31 Mar 20 | 196 | 8 | 124 | 6 |
| 31 Dec 19 | 189 | 11 | 117 | 5 |
| 30 Sep 19 | 179 | 9 | 111 | 5 |
| 30 Jun 19 | 166 | 8 | 104 | 5 |
| 31 Mar 19 | 155 | 8 | 99 | 5 |
| 31 Dec 18 | 144 | 7 | 92 | 5 |
| 30 Sep 18 | 132 | 6 | 85 | 5 |
| 30 Jun 18 | 124 | 6 | 80 | 5 |
| 31 Mar 18 | 116 | 7 | 75 | 5 |
| 31 Dec 17 | 109 | 6 | 71 | 5 |
| 30 Sep 17 | 103 | 6 | 68 | 5 |
| 30 Jun 17 | 97 | 5 | 64 | 5 |
| 31 Mar 17 | 91 | 2 | 58 | 5 |
| 31 Dec 16 | 85 | 2 | 53 | 4 |
| 30 Sep 16 | 77 | 0 | 48 | 5 |
| 30 Jun 16 | 71 | 0 | 44 | 5 |
| 31 Mar 16 | 66 | -1 | 41 | 4 |
| 31 Dec 15 | 63 | 0 | 38 | 4 |
| 30 Sep 15 | 60 | 0 | 35 | 4 |
| 30 Jun 15 | 55 | 0 | 33 | 3 |
| 31 Mar 15 | 49 | 0 | 30 | 3 |
| 31 Dec 14 | 48 | 0 | 28 | 3 |
| 31 Dec 13 | 37 | 1 | 23 | 2 |
Quality Earnings: TCMD has high quality earnings.
Growing Profit Margin: TCMD's current net profit margins (5.4%) are lower than last year (9.2%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: TCMD's earnings have grown significantly by 23.4% per year over the past 5 years.
Accelerating Growth: TCMD's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: TCMD had negative earnings growth (-38.1%) over the past year, making it difficult to compare to the Medical Equipment industry average (10.4%).
Return on Equity
High ROE: TCMD's Return on Equity (7.4%) is considered low.